Dr. Neel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
522 First Avenue
Smilow Building Twelfth Floor, Suite 1201
New York, NY 10016Phone+1 212-263-3276Fax+1 212-263-9190- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1983 - 1987
- Weill Cornell MedicineClass of 1983
Certifications & Licensure
- MA State Medical License 1984 - 2026
Publications & Presentations
PubMed
- 94 citationsThe current state of the art and future trends in RAS-targeted cancer therapies.Salman R Punekar, Vamsidhar Velcheti, Benjamin G Neel, Kwok-Kin Wong> ;Nature Reviews. Clinical Oncology. 2022 Oct 1
- 4 citationsSignal transfer in human protein tyrosine phosphatase PTP1B from allosteric inhibitor P00058.Yuri N. Chirgadze, Kevin P. Battaile, Ilya V. Likhachev, Nikolay K. Balabaev, Roni D. Gordon, Vladimir Romanov, Andres Lin, Robert Karisch, Robert Lam, Max Ruzanov, Ev...> ;Journal of Biomolecular Structure & Dynamics. 2021 Oct 27
- 14 citationsDual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy.Sime Brkic, Simona Stivala, Alice Santopolo, Jakub Szybinski, Sarah Jungius, Jakob Passweg, Dimitrios A. Tsakiris, Stefan Dirnhofer, Gregor Hutter, Katharina Leonards,...> ;Leukemia. 2021 Sep 3
- Join now to see all
Journal Articles
- The Gp1ba-Cre Transgenic Mouse: A New Model to Delineate Platelet and Leukocyte FunctionsBenjamin Neel, MD, Blood
Press Mentions
- NYU Langone Health’s Perlmutter Cancer Center Continues to Grow in Brooklyn, Provide Care to Diverse PopulationsApril 5th, 2023
- Can Targeted Therapy for KRAS Mutations Double as Part of Immunotherapy?October 31st, 2022
- Combining Targeted, Immune Therapies Kills Treatment-Resistant Cancer CellsOctober 17th, 2022
- Join now to see all
Grant Support
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute2008–2012
- The RAS/MAPK Pathway In Cardiovascular Disease.National Heart, Lung, And Blood Institute2011
- Human SHP2 (PTPN11) Mutations And Cardiac Valve DevelopmentNational Heart, Lung, And Blood Institute2009–2010
- Role Of GAB2 And SHP2 In Hematopoietic SignallingNational Cancer Institute2008–2010
- Human SHP2 (PTPN11) Mutations And Cardiac Valve DevelopmentNational Heart, Lung, And Blood Institute2007–2008
- Role Of GAB2 And SHP2 In Hematopoietic SignallingNational Cancer Institute2006–2008
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute2004–2007
- EM Localization Of PTP1B &Rtk &Ptp1b InteractionsNational Center For Research Resources2004–2006
- Role Of PTP1B In Body Mass RegulationNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Role Of BAG2 And SHP2 In Hematopoietic SignallingNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Training Program In Cancer BiologyNational Cancer Institute2000–2004
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute1999–2003
- GAB2 And SHP2 In Hematopoiesis And LeukemogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2002
- 2002 Faseb Meeting On Protein PhosphatasesNational Cancer Institute2002
- Molecular And Genetic Basis Of Cell ProliferationNational Cancer Institute2001
- Role Of Ptpu And SHPTP2 In Endothelial CellsNational Heart, Lung, And Blood Institute1997–2001
- Hematologic Diseases Resulting From Defects Of Tyrosine PhosphatasesNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2001
- Regulation Of B Cell Signaling By Shptp-1National Cancer Institute1996–2000
- Regulation Of EPO Receptor Signaling By SH-PTP1National Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Signal Transduction By Non-Transmembrane PTP SNational Cancer Institute1994–1998
- Molecular Analysis Of Supression Of TransformationNational Cancer Institute1989–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: